Literature DB >> 9112448

Pediatric medulloblastoma: radiation treatment technique and patterns of failure.

R Miralbell1, A Bleher, P Huguenin, G Ries, R Kann, R O Mirimanoff, M Notter, P Nouet, S Bieri, P Thum, H Toussi.   

Abstract

PURPOSE: In this study factors are analyzed that may potentially influence the site of failure in pediatric medulloblastoma. Patient-related, disease-related, and treatment-related variables are analyzed with a special focus on radiotherapy time-dose and technical factors. METHODS AND MATERIALS: Eighty-six children and adolescents with a diagnosis of medulloblastoma were treated in Switzerland during the period 1972-1991. Postoperative megavoltage radiotherapy was delivered to all patients. Simulation and portal films of the whole-brain irradiation (WBI) fields were retrospectively reviewed in 77 patients. The distance from the field margin to the cribiform plate and to the floor of the temporal fossa was carefully assessed and correlated with supratentorial failure-free survival. In 19 children the spine was treated with high-energy electron beams, the remainder with megavoltage photons. Simulation and port films of the posterior fossa fields were also reviewed in 72 patients. The field size and the field limits were evaluated and correlated with posterior fossa failure-free survival.
RESULTS: In 36 patients (47%) the WBI margins were judged to miss the inferior portion of the frontal and temporal lobes. Twelve patients failed in the supratentorial region and 9 of these patients belonged to the group of 36 children in whom the inferior portion of the brain had been underdosed. On multivariate analysis only field correctness was retained as being significantly correlated with supratentorial failure-free survival (p = 0.049). Neither the total dose to the spinal theca nor the treatment technique (electron vs. photon beams) were significantly correlated with outcome. Posterior fossa failure-free survival was not influenced by total dose, overall treatment time, field size, or field margin correctness. Overall survival was not influenced by any of the radiotherapy-related technical factors.
CONCLUSION: A correlation between WBI field correctness and supratentorial failure-free survival was observed. Treatment protocols should be considered that limit supratentorial irradiation mainly to subsites at highest risk of relapse. Optimized conformal therapy or proton beam therapy may help to reach this goal. Treating the spine with electron beams was not deletereous. A significant correlation between local control and other technical factors was not observed, including those relating to posterior fossa treatment. The use of small conformal tumor bed boost fields may be prefered to the larger posterior fossa fields usually considered as the standard treatment approach.

Entities:  

Mesh:

Year:  1997        PMID: 9112448     DOI: 10.1016/s0360-3016(96)00569-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region.

Authors:  Li-Min Sun; Shyh-An Yeh; Chong-Jong Wang; Eng-Yen Huang; Hui-Chun Chen; Hsuan-Chih Hsu; Steve P Lee
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

2.  Fast imaging employing steady-state acquisition (FIESTA) MRI to investigate cerebrospinal fluid (CSF) within dural reflections of posterior fossa cranial nerves.

Authors:  David J Noble; Daniel Scoffings; Thankamma Ajithkumar; Michael V Williams; Sarah J Jefferies
Journal:  Br J Radiol       Date:  2016-09-29       Impact factor: 3.039

3.  Large cell/anaplastic medulloblastoma is associated with poor prognosis-a retrospective analysis at a single institute.

Authors:  Pin-I Huang; Shih-Chieh Lin; Yi-Yen Lee; Donald Ming-Tak Ho; Wan-Yuo Guo; Kai-Ping Chang; Feng-Chi Chang; Muh-Lii Liang; Hsin-Hung Chen; Yu-Ming Liu; Sang-Hue Yen; Tai-Tong Wong; Yi-Wei Chen
Journal:  Childs Nerv Syst       Date:  2017-05-09       Impact factor: 1.475

4.  HIT '91 (prospective, co-operative study for the treatment of malignant brain tumors in childhood): accuracy and acute toxicity of the irradiation of the craniospinal axis. Results of the quality assurance program.

Authors:  R D Kortmann; B Timmermann; J Kühl; N Willich; M Flentje; C Meisner; M Bamberg
Journal:  Strahlenther Onkol       Date:  1999-04       Impact factor: 3.621

5.  High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031).

Authors:  Nancy J Tarbell; Henry Friedman; William R Polkinghorn; Torunn Yock; Tianni Zhou; Zhengjia Chen; Peter Burger; Patrick Barnes; Larry Kun
Journal:  J Clin Oncol       Date:  2013-07-15       Impact factor: 44.544

6.  Recurrence in childhood medulloblastoma.

Authors:  Monika Warmuth-Metz; Sophia Blashofer; André O von Bueren; Katja von Hoff; Brigitte Bison; Fabian Pohl; Rolf-Dieter Kortmann; Torsten Pietsch; Stefan Rutkowski
Journal:  J Neurooncol       Date:  2010-11-11       Impact factor: 4.130

7.  Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches.

Authors:  James C Marsh; Benjamin T Gielda; Arnold M Herskovic; Ross A Abrams
Journal:  J Oncol       Date:  2010-06-27       Impact factor: 4.375

8.  Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.

Authors:  Stefan Dietzsch; Annett Braesigk; Clemens Seidel; Julia Remmele; Ralf Kitzing; Tina Schlender; Martin Mynarek; Dirk Geismar; Karolina Jablonska; Rudolf Schwarz; Montserrat Pazos; Marc Walser; Silke Frick; Kristin Gurtner; Christiane Matuschek; Semi Ben Harrabi; Albrecht Glück; Victor Lewitzki; Karin Dieckmann; Martin Benesch; Nicolas U Gerber; Stefan Rutkowski; Beate Timmermann; Rolf-Dieter Kortmann
Journal:  Strahlenther Onkol       Date:  2020-11-23       Impact factor: 3.621

9.  Radiation therapy quality in CCG/POG intergroup 9961: implications for craniospinal irradiation and the posterior fossa boost in future medulloblastoma trials.

Authors:  Bernadine Donahue; Mary A H Marymont; Sandra Kessel; Matthew K Iandoli; Thomas Fitzgerald; Emiko Holmes; Mehmet Kocak; James M Boyett; Amar Gajjar; Roger J Packer
Journal:  Front Oncol       Date:  2012-12-11       Impact factor: 6.244

10.  Isolated Supratentorial Intraventricular Recurrence of Medulloblastoma.

Authors:  Kingsley O Abode-Iyamah; Nolan Winslow; Oliver Flouty; Patricia Kirby
Journal:  J Korean Neurosurg Soc       Date:  2015-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.